Growth hormone enhances natural killer cell activity against glioma

Journal of Nippon Medical School

Volumn 72, Issue 6, 2005, Pages 335-340

  Shimizu, Kenji ^a   Adachi, Koji ^a   Teramoto, Akira ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

9L glioma; Growth hormone; Natural killer cell activity

Indexed keywords

ADENOHYPOPHYSIS HORMONE; FLUORESCEIN ISOTHIOCYANATE; GANGLIOSIDE ANTIBODY; GANGLIOTETRAOSYLCERAMIDE ANTIBODY; PROPIDIUM IODIDE; RECOMBINANT GROWTH HORMONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVITY; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY TEST; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTER; GLIOMA; HORMONE ACTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NATURAL KILLER CELL; NONHUMAN; RAT; SPLEEN CELL; TARGET CELL;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GLIOMA; GROWTH HORMONE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RATS; RATS, INBRED F344;

EID: 30744456556     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.72.335     Document Type: Article

References (16)

1. Fabris N, Pierpaoli W, Sorkin E: Hormones and the immunological capacity III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp immunol 1971; 9: 209-225.
2. Pierpaoli W, Sorkin E: Relationship between thymus and hypophysis. Nature 1967; 215: 834-837.
3. Pierpaoli W, Sorkin E: Hormones and immunological capacity I. Effect of heterologous anti-growth hormone ( ASTH ) antiserum on thymus and peripheral lymphatic tissue in mice. Induction of a wasting syndrome. J Immunol 1968; 101: 1036-1043.
4. Pierpaoli W, Baroni C, Fabris N, Sorkin E: Hormones and immunological capacity II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin. Immunology 1969; 16: 217-230.
5. Baroni C, Fabris N, Bertoli G: Effects of hormones on development and function of lymphoid tissues: Synergistic action of thyroxine and somatotropic hormone in pituitary dwarf mice. Immunology 1969; 17: 303-314.
6. Sabharwal P, Zwilling B, Glaser R, Malarkey WB: Cellular immunity in patients with acromegaly and prolactinomas. Prog Neuroendocrinol Immunol 1992; 5: 120-125.
7. Crist DM, Kraner JC: Supplemental growth hormone increases the tumor cytotoxic activity of natural killer cells in healthy adults with normal growth hormon secretion. Metabolism 1990; 39: 1320-1324.
8. Kiess W, Malozowski S, Gelato M, Butenandt O, Doerr H, Crisp B, Eisl E, Maluish A, Belohradsky BH: Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. Clin Immunol Immunopathol 1988; 48: 85-94.
9. Bozzola M, Valtorta A, Moretta A, Cisternino M, Biscaldi I, Schimpff RM: In vitro and in vivo effect of growth hormone on cytotoxic activity. J Pediatr 1990; 117: 596-599.
10. Barth RF: Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 1998; 36: 91-102.
11. Kooijman R, Willems M, De Haas CJC, Rijkers GT, Schuurmans AL, Van Buul-Offers SC, Heijnen CJ, Zegers BJ: Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992; 131: 2244-2250.
12. Badolato R, Bond HM, Valerio G, Petrella A, Morrone G, Waters MJ, Venuta S, Tenore A: Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J Clin Endocrinol Metab 1994; 79: 984-990.
13. Li CH: Some aspects on the biochemistry of growth hormone. In Basic and clinical aspects of growth hormone (Bercu BB, ed), 1988; pp 33-42, Serono Synposia, New York.
14. Kotzmann H, Koller M, Czernin S, Clodi M, Svoboda T, Riedl M, Boltz-Nitulescu G, Zielinski CC, Luger A: Effect of elevated growth hormone concentrations on the phenotype and functions of human lymphocytes and natural killer cells . Neuroendocrinology 1994; 60: 618-625.
15. Colao A, Merola B, Ferone D, Lombardi G: Acromegaly. J Clin Endocrinol Metab 1997; 82: 2777-2781.
16. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC: Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol 1990; 32: 65-71.